Prof. Fabio Pacelli
  • Chi sono
  • Patologie trattate
    • Patologia oncologica
    • Patologia benigna
  • Pubblicazioni
  • Videogallery
  • Dicono di me
  • Prenota una visita
  • Chi sono
  • Patologie trattate
    • Patologia oncologica
    • Patologia benigna
  • Pubblicazioni
  • Videogallery
  • Dicono di me
  • Prenota una visita

/Pubblicazioni/Risk factor analysis for involvement of resection margins in gastric and esophagogastric junction cancer: an Italian multicenter study

Risk factor analysis for involvement of resection margins in gastric and esophagogastric junction cancer: an Italian multicenter study

By Prof. Fabio Pacelli - In Pubblicazioni - 25 Ottobre 2016

Gastric Cancer

Risk factor analysis for involvement of resection margins in gastric and esophagogastric junction cancer: an Italian multicenter study

Gastric Cancer. 2016 Jan 5.

Bissolati M, Desio M, Rosa F, Rausei 5, Marrelli D, Baiocchi GL, De Manzoni G, Chiari D, Guarneri G, Pacelli F, De Franco L, Molfino 5, Cipollari C, Orsenigo E.

Share

  • Google+
  • Twitter
  • Facebook
← Naso-gastric or naso-jejunal decompression after partial distal gastrectomy for gastric cancer. Final results of a multicenter prospective randomized trial
Laparoscopic Splenectomy for Secondarv Cytoreduction in Ovarian Cancer Patients With Localized Spleen Recurrence: Feasibility and Technique →

Ultimi articoli

  • Systemic chemotherapy and pressurized intraperitoneal aerosol chemotherapy (PIPAC): A bidirectional approach for gastric cancer peritoneal metastasis
    Systemic chemotherapy and pressurized intraperitoneal aerosol chemotherapy (PIPAC): A bidirectional approach for gastric cancer peritoneal metastasis

    Surgical Oncology; 2020 34:270-275. Di G...

  • Systemic chemotherapy and pressurized intraperitoneal aerosol chemotherapy (PIPAC): A case report of a multimodal treatment for peritoneal metastases of pancreatic origin
    Systemic chemotherapy and pressurized intraperitoneal aerosol chemotherapy (PIPAC): A case report of a multimodal treatment for peritoneal metastases of pancreatic origin

    International Journal of Surgery Case Re...

  • Pressurized intraperitoneal aerosol chemotherapy with cisplatin and doxorubicin or oxaliplatin for peritoneal metastasis from pancreatic adenocarcinoma and cholangiocarcinoma
    Pressurized intraperitoneal aerosol chemotherapy with cisplatin and doxorubicin or oxaliplatin for peritoneal metastasis from pancreatic adenocarcinoma and cholangiocarcinoma

    Therapeutic Advances in Medical Oncology...

  • Hyperthermic intraperitoneal chemotherapy (HIPEC) for peritoneal malignancies using new hybrid CO2 system: preliminary experience in referral center
    Hyperthermic intraperitoneal chemotherapy (HIPEC) for peritoneal malignancies using new hybrid CO2 system: preliminary experience in referral center

    Updates in Surgery; 2019 71:555-560. Cia...

  • The Cholegas trial: long-term results of prophylactic cholecystectomy during gastrectomy for cancer‚ a randomized-controlled trial
    The Cholegas trial: long-term results of prophylactic cholecystectomy during gastrectomy for cancer‚ a randomized-controlled trial

    Gastric Cancer; 2019 22:632-639. Bencini...

Archivi

  • Febbraio 2021
  • Febbraio 2018
  • Gennaio 2018
  • Novembre 2016
  • Ottobre 2016
  • Luglio 2013
  • Maggio 2012

CONTATTI

Prof. Fabio Pacelli
E-mail: fabio.pacelli@policlinicogemelli.it

Policlinico Universitario "A. Gemelli"
Direttore UOC Chirurgia del peritoneo e del retroperitoneo
Largo F. Vito, 1 - 00168 Roma
Tel. (+39) 06 30157255

PRENOTA UNA VISITA

Visite private - Tel. (+39) 06 88818881

Visite online - Videoconsulto@policlinicogemelli.it

In alternativa utilizza la nostra FORM DI CONTATTO per inviarci un messaggio

Copyright © 2012-. All Rights Reserved - Powered by Apiweb Srl